TABLE 1.
Baseline characteristics of the study cohort before and after propensity score matching.
| Baseline characteristic | Before PSM (n = 623) | SMD (before) | After PSM (n = 514) | SMD (after) | ||
|---|---|---|---|---|---|---|
| Clop. (n = 308) | Tica. (n = 315) | Clop. (n = 257) | Tica. (n = 257) | |||
| Age (years) | 57.44 ± 10.81 | 60.12 ± 9.68 | 0.261 | 58.02 ± 10.31 | 59.26 ± 9.49 | 0.125 |
| Male, n (%) | 179 (58.12%) | 164 (52.06%) | 0.122 | 137 (53.31%) | 133 (51.75%) | 0.031 |
| Hypertension, n (%) | 187 (60.71%) | 207 (65.71%) | 0.104 | 162 (63.04%) | 167 (64.98%) | 0.040 |
| Diabetes, n (%) | 121 (39.29%) | 144 (45.71%) | 0.130 | 111 (43.19%) | 119 (46.30%) | 0.063 |
| Smoking, n (%) | 140 (45.45%) | 127 (40.32%) | 0.104 | 112 (43.58%) | 105 (40.86%) | 0.055 |
| NIHSS score (x ± s) | 3.42 ± 1.52 | 3.04 ± 1.84 | 0.225 | 3.35 ± 1.55 | 3.18 ± 1.66 | 0.106 |
| LDL-C, mmol/L | 3.70 ± 1.49 | 3.99 ± 1.62 | 0.186 | 3.80 ± 1.47 | 3.94 ± 1.43 | 0.097 |
Data are presented as mean ± standard deviation or number (percentage). Clop., clopidogrel group; Tica., ticagrelor group; NIHSS, national institutes of health stroke scale; LDL-C, low-density lipoprotein cholesterol.